2026-01-29 - Analysis Report
**Company Overview**
Applied Materials is a leading company in the development and manufacture of semiconductor materials and related products.

**Return Rate Comparison with S&P 500 (VOO)**

* Ticker: AMAT
* Cumulative Return (review stock): 487.01%
* Cumulative Return (comparison stock, S&P 500): 128.51%
* Divergence (max: 358.50, min: -20.10, current: 358.50, relative divergence: 100.00%)

The review stock has significantly outperformed the comparison stock, with a cumulative return of 487.01% compared to 128.51%. This indicates a high degree of divergence, with the review stock leading the comparison stock by 358.50%.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 0.0% | 41.7% | -9.0% | 1.6 | 26.5B |
| 2017-2019  | 29.0% | 41.7% | 4.0% | 1.7 | 49.5B |
| 2018-2020  | 52.0% | 42.9% | 28.0% | 1.5 | 69.9B |
| 2019-2021  | 255.0% | 42.9% | 191.0% | 1.6 | 127.5B |
| 2020-2022  | 43.0% | 52.7% | 39.0% | 1.6 | 78.9B |
| 2021-2023  | 65.0% | 52.7% | 47.0% | 1.8 | 131.3B |
| 2022-2024  | -21.0% | 45.5% | -50.0% | 1.8 | 131.8B |
| 2023-2025  | 211.0% | 48.8% | 136.0% | 1.8 | 208.3B |

The analysis indicates a high degree of volatility in the review stock, with a high CAGR and MDD. The Alpha and Beta values suggest a moderate level of market sensitivity.

**Recent Stock Price Fluctuations**

* Close: $332.71
* Last-market: {'price': 338.39, 'previousClose': 332.71, 'change': 1.71}
* 5-day SMA: $323.71
* 20-day SMA: $300.06
* 60-day SMA: $264.63

The review stock has recently experienced a sharp rebound, with a large increase in price.

**RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.70
* RSI: 66.32
* PPO: 0.29
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.70)
Recent (20 days) relative divergence change: 2.90 (+): improving
7-day Rank change: 27 (+): rank up
7-day Dynamic Expected Return change: 32.50 (+): improving
Expected Return (%): 33.50%

The review stock is currently in a neutral position, with an RSI indicating a moderate level of momentum. The PPO indicator suggests a potential for a short-term decline.

**Recent News & Significant Events**

* Analysts Expect Applied Materials Stock to Dominate in 2026. Should You Buy Shares Now? - Yahoo Finance (link)
* AMAT stock: Mizuho sees ‘significant acceleration’ in WFE, upgrades rating - Investing.com (link)
* Mizuho upgrades Applied Materials to Outperform as WFE spending accelerates - Seeking Alpha (link)
* 2 Top Nasdaq Stocks to Buy Before They Skyrocket in 2026 - The Motley Fool (link)
* Applied Materials (AMAT) Has a Shortage That Can’t Be Met, Says Jim Cramer - Insider Monkey (link)
* AMAT stock pops on Mizuho upgrade as Applied Materials gets a $370 target - TechStock² (link)

The review stock has been the subject of recent upgrades and positive news, including an upgrade from Mizuho to Outperform.

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.74 (~Buy)
- Opinions: 33
- Target Price (avg/high/low): 317.61 / 425.00 / 190.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-08-21 | 2.23 | 7.30 B$ |
| 2025-05-22 | 2.64 | 7.10 B$ |
| 2025-02-20 | 1.46 | 7.17 B$ |
| 2024-08-22 | 2.06 | 6.78 B$ |
| 2025-08-21 | 2.06 | 6.78 B$ |

The review stock has experienced strong earnings growth in recent quarters, with revenue increasing by 4.5% YoY.

**Financial Information: Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $6.80B | 48.01% |
| 2025-07-31 | $7.30B | 48.78% |
| 2025-04-30 | $7.10B | 49.08% |
| 2025-01-31 | $7.17B | 48.79% |
| 2024-10-31 | $7.04B | 47.34% |

The review stock has maintained a high profit margin over the past year, with a slight decline in revenue.

**Financial Information: Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $20.41B | 9.29% |
| 2025-07-31 | $19.50B | 9.12% |
| 2025-04-30 | $18.96B | 11.27% |
| 2025-01-31 | $18.62B | 6.36% |
| 2024-10-31 | $19.00B | 9.11% |

The review stock has maintained a moderate ROE over the past year, with a slight decline in equity.

**Comprehensive Analysis**

* High divergence between the review stock and comparison stock (358.50%)
* Sharp rebound in stock price ( recent 5-day SMA: $323.71, recent 20-day SMA: $300.06, recent 60-day SMA: $264.63)
* Neutral position in RSI (66.32), with a potential for a short-term decline in PPO (0.29)
* Recent upgrades and positive news, including an upgrade from Mizuho to Outperform
* Strong earnings growth in recent quarters, with revenue increasing by 4.5% YoY
* High profit margin over the past year (48.01%-49.08%), with a slight decline in revenue
* Moderate ROE over the past year (6.36%-11.27%), with a slight decline in equity

Overall, the review stock is in a strong position, with a high degree of divergence, recent upgrades, and strong earnings growth. However, the stock is currently in a neutral position, with a potential for a short-term decline.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.